(redirected from pancreatic cancer)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to pancreatic cancer: pancreatitis, pancreas


Fifth letter of a Nasdaq stock symbol specifying that it is the third preferred bond of the company.


1. On a stock transaction table, a symbol indicating that a dividend was paid after a stock split.

2. A symbol appearing next to a bond listed on NASDAQ indicating that the bond is a company's third preferred bond. All NASDAQ listings use a four-letter abbreviation; if the letter "I" follows the abbreviation, this indicates that the security being traded is a third preferred bond.


Used in the dividend column of stock transaction tables to indicate that the dividend was paid after a stock dividend or split: Lehigh s.20i.
Mentioned in ?
References in periodicals archive ?
Precision-Panc will run the new trial, which will focus on bringing a precision medicine approach to pancreatic cancer for the first time in the UK, according to the University of Glasgow.
What's more, research is also progressing in the field of early pancreatic cancer detection.
We have already discovered that for patients with pancreatic cancer who do undergo surgery, chemotherapy can improve survival rates by at least 10%.
Now the couple are holding a fundraising afternoon tea for the Pancreatic Cancer Research Fund.
This report also provides qualitative assessment of pancreatic cancer, its stages, and approved drugs for pNET.
Pancreatic cancer is often diagnosed late when it is too advanced for surgery, the only potential curative treatment.
The 2012 estimated incidences of pancreatic cancer were approximately 80,000 in the Europe Community and 43,000 in the United States of America.
Secondly they emphasize that when assessing someone's individual risk of developing pancreatic cancer it may be important to assess not just family history of pancreatic cancer but other malignancies too.
Professor Kevin Ryan, Cancer Research UK scientist based at the Cancer Research UK Beatson Institute, said: This is an exciting opportunity to develop new drugs for pancreatic cancer where there is an urgent need for new treatments.
According to the study, men and women who took low-dose aspirin regularly had 48 percent reduction in their risk for developing pancreatic cancer and protection against pancreatic cancer ranged from 39 percent reduction in risk for those who took low-dose aspirin for six years or less, to 60 percent reduction in risk for those who took it for more than 10 years.
Pancreatic cancer is typically diagnosed through an invasive and complicated biopsy, but a discovery by researchers at the UCLA School of Dentistry may be one major step toward creating a noninvasive tool that would enable the detection of pancreatic cancer using saliva.

Full browser ?